Showing Latest Publications

Which CFPB Will We Get?

TOTM Todd mentions Elizabeth Warren’s “kick off” speech for the CFPB, in which she accepts the new “President and Special Advisor to the Secretary of the . . .

Todd mentions Elizabeth Warren’s “kick off” speech for the CFPB, in which she accepts the new “President and Special Advisor to the Secretary of the Treasury” gig, and tells us what the new Bureau is all about…

Read the full piece here

Continue reading
Financial Regulation & Corporate Governance

Amicus Brief, Rehearing En Banc, TiVo Inc. v. EchoStar Corp., et al., Fed. Cir.

Amicus Brief "EchoStar’s appeal presents a stark choice on the proper method for dealing with a repeat patent infringer against whom the District Court has issued an initial injunction followed by a contempt decree, which between them have yet to provide TiVo with an ounce of effective relief against EchoStar’s unlawful behavior..."

Summary

“EchoStar’s appeal presents a stark choice on the proper method for dealing with a repeat patent infringer against whom the District Court has issued an initial injunction followed by a contempt decree, which between them have yet to provide TiVo with an ounce of effective relief against EchoStar’s unlawful behavior. EchoStar takes the position that the entire convoluted six-year history of this dispute should be ignored in passing on the validity of its purported present work- around of TiVo’s ‘389 patent. In so doing, its apparent objective is to win a war of attrition against TiVo. The first part of that strategy is to use its current modified DVR for as long as it can tie up TiVo through tactics of litigation delay that allow it to reap all the collateral gains from patent infringement. Once stopped with the first work-around, it may well repeat the same cycle of delay a second time.

For EchoStar, this approach it is a no-lose strategy. EchoStar wins big if it can persuade a court that its work-around comes close to, but does not cross, the infringement line. EchoStar also wins if it loses a new infringement suit so long as it needs only pay damages that amount to a small fraction of the economic gains it derives from following its unlawful strategy. Then it can start the cycle anew with a second work-around, and, if need be, a third. Unless prompt and decisive measures are taken, EchoStar will profit handsomely from its own wrongdoing…”

Continue reading
Intellectual Property & Licensing

TESTIMONY OF GEOFFREY A. MANNE ON COMMERCIALIZING INNOVATION

Written Testimonies & Filings Summary I would like to thank Chairman Conyers, Ranking Member Smith, Chairman Johnson and Ranking Member Coble for inviting me to testify. Members of the . . .

Summary

I would like to thank Chairman Conyers, Ranking Member Smith, Chairman Johnson and Ranking Member Coble for inviting me to testify. Members of the Committee: My name is Geoffrey A. Manne. I am the founder and executive director of the International Center for Law and Economics (or “ICLE”)—a global think tank devoted to bringing academic rigor to policy debates in the areas of antitrust, intellectual property, and financial regulation. I also teach Law and Economics at Lewis and Clark Law School in Portland, Oregon, where I am a Lecturer. I’ve written widely on competition policy and innovation. I’m the co-editor of a forthcoming volume on the topic from Cambridge University Press, Competition Policy and Intellectual Property Law Under Uncertainty: Regulating Innovation (with Joshua D. Wright) and the co-author (also with Joshua Wright) of two articles on the limits of antitrust in the digital economy: Innovation and the Limits of Antitrust (published in the Journal of Competition Law and Economics) and The Case Against the Case Against Google (forthcoming in the Harvard Journal of Law and Public Policy). In the interest of transparency, Google, among several other companies, has in the past supported ICLE’s work.

Economists have been studying antitrust since the very beginnings of the study of economics itself—Adam Smith even has a discussion on the subject in The Wealth of Nations. But economics—and by extension legal scholarship—has only come into its own and developed rigorous, sound and evidence-based analysis of the topic since about the 1970s. There is an enormous amount about the economic implications of business conduct that we still don’t understand (and some that we do seem to have a handle on), but our antitrust laws nevertheless obligate us to soldier on, developing sound expectations about the anti- or pro-competitive implications of various forms of business conduct nonetheless.

And while antitrust is not unique in operating under conditions of fundamental uncertainty, antitrust may be unique in foisting the burden of this uncertainty onto essentially economic conclusions: The touchstone of antitrust enforcement is the speculative economic implications of scrutinized conduct rather than its adherence to specific rules or legal tenets. As a result, we are forced to assess possible antitrust interventions within a sometimes-unsatisfying “decision-theoretic” framework—weighing the likelihood and the costs of erroneous enforcement against the likelihood and costs of erroneous nonenforcement.

For reasons I will discuss briefly below, this essential analysis tends to counsel against, rather than for, enforcement in many circumstances, and this is particularly true in nascent, evolving and technologically-innovative markets where ignorance about market structure, competition, technology and consumer demand is legion. Following my general remarks, I will spend some time discussing the implications of this reality for assessing the competitive implications of the pending Google/ITA merger. At the end of my prepared remarks I have a brief discussion of the role of privacy concerns in antitrust analysis.

The antitrust landscape has changed dramatically in the last decade. Within the last two years alone, the United States Department of Justice has held hearings on the appropriate scope of Section 2, issued a comprehensive Report, and then repudiated it; and the European Commission has risen as an aggressive leader in single firm conduct enforcement by bringing abuse of dominance actions and assessing heavy fines against firms including Qualcomm, Intel, and Microsoft. In the United States, two of the most significant characteristics of the “new” antitrust approach have been a more intense focus on innovative companies in high-tech industries and a weakening of longstanding concerns that erroneous antitrust interventions will hinder economic growth. But this focus is dangerous, and these concerns should not be dismissed so lightly.

Today’s high-tech bête noir is Google. Close scrutiny of the complex economics of Google’s technology, market and business practices reveals a range of real but subtle, pro-competitive explanations for features that have been held out instead as anticompetitive. Application of the relevant case law then reveals a set of concerns where economic complexity and ambiguity, coupled with an insufficiently-deferential approach to innovative technology and pricing practiced in the most relevant precedent (the D.C. Circuit’s decision in Microsoft), portend a potentially erroneous—and costly—result. A better analysis, by contrast, would embrace the cautious and evidence-based approach to uncertainty, complexity and dynamic innovation contained within the wellestablished “error cost framework.” And while there is an abundance of errorcost concern in the relevant Supreme Court precedent, there is a real risk that the current, aggressive approach to antitrust error, coupled with the uncertain economics of Google’s innovative conduct, will nevertheless yield costly interventions. The point is not that we know that Google—or any other high-tech company’s—conduct is pro-competitive, but rather that the very uncertainty surrounding it counsels caution, not aggression.

The error-cost framework in antitrust originates with Judge Frank Easterbrook’s analysis in his seminal paper, The Limits of Antitrust, itself built on twin premises: first, that false positives are more costly than false negatives because self-correction mechanisms mitigate the latter but not the former, and second, that errors of both types are inevitable because distinguishing procompetitive conduct from anti-competitive conduct is an inherently difficult task, especially in a single-firm context.

While economists have applied this framework fruitfully to several business practices that have attracted antitrust scrutiny, its application to antitrust intervention in markets where innovation is a critical part of the competitive landscape is less-well-developed. While much has been said about the relationship between innovation and antitrust, often in the way of broad pronouncements that innovation either renders antitrust essential to economic growth or entirely unnecessary, the error-cost framework allows for greater precision in policy prescriptions and a more nuanced approach. Some of the implications are well understood in the current body of literature and others have been frequently ignored or remain entirely unrecognized.

In brief, given the link between innovation and economic growth, the stakes of “getting it right” are high. Caution and humility are warranted in light of both the historical hostility towards innovative business practices by competition policy as well as the large gaps of empirically-validated theory in the economic literature on competition and innovation. The traditional problem of identifying and distinguishing pro-competitive from anticompetitive conduct faced by enforcers and courts in all antitrust cases is a difficult one. But those difficulties are exacerbated in innovative industries.

Both product and business innovations involve novel practices, and such practices generally result in monopoly explanations from the economics profession followed by hostility from the courts (though sometimes in reverse order) and then a subsequent, more nuanced economic understanding of the business practice usually recognizing its pro-competitive virtues. This sequence and outcome is exactly what one might expect in a world where economists’ career incentives skew in favor of generating models that demonstrate inefficiencies and debunk the economics status quo, while defendants engaged in business practices that have evolved over time through trial and error have a difficult time articulating a justification that fits one of a court’s checklist of acceptable answers. In the words of Nobel economist Ronald Coase,

[i]f an economist finds something—a business practice of one sort or another—that he does not understand, he looks for a monopoly explanation. And as in this field we are rather ignorant, the number of un-understandable practices tends to be rather large, and the reliance on monopoly explanations frequent.”

From an error-cost perspective, the critical point is that antitrust scrutiny of innovation and innovative business practices is likely to be biased in the direction of assigning higher likelihood that a given practice is anticompetitive than the subsequent literature and evidence will ultimately suggest is reasonable or accurate.

Thus while many business practices are criticized by competitors and others as anticompetitive—and sometimes they are, of course—I believe it would be prudent to consider and give greater weight to the pro-competitive explanations as well as the anti-competitive ones. The fundamental truth of antitrust analysis is that the very same conduct (aggressive competition) that could be anticompetitive could also be pro-competitive; there is no easy way to suss out the difference on the basis of simple (or even complex) legislative or judicial language. The cost of hasty intervention is the loss to consumers of the benefits of that aggressive competition, both directly and, perhaps more importantly, by deterring future actions that may likewise attract costly interventions and penalties. Intervention tends to be final, stopping (and deterring) potentially-valuable conduct in its tracks. On the other hand, nonintervention under uncertainty permits the possible pro-competitive bounty to materialize and allows both the competitive marketplace as well as future enforcers to mitigate anticompetitive outcomes that may arise.

Continue reading
Innovation & the New Economy

Now, Everyone, Gasp In Surprise

TOTM Alan Greenspan has been revered in political and media circles since his benevolent reign over times of fortune as the Chair of the US Federal . . .

Alan Greenspan has been revered in political and media circles since his benevolent reign over times of fortune as the Chair of the US Federal Reserve. Now Mr. Greenspan has acknowledged what many of us have been saying for a long time: fiscal stimulus didn’t work. (insert gasps of surprise here)

Read the full piece here

Continue reading

The Microsoft-Google Antitrust Wars and Public Choice: There is Too An Argument Against Rival Involvement in Antitrust Enforcement

TOTM How should an economist interpret the fact that Microsoft appears to be “behind” recent enforcement actions against Google in the United States and, especially, in . . .

How should an economist interpret the fact that Microsoft appears to be “behind” recent enforcement actions against Google in the United States and, especially, in Europe?

“With skepticism!”  Is the answer I suspect many readers will offer upon first glance.  There is a long public choice literature, and long history in antitrust itself, that suggests that one should be weary of private enforcement of the antitrust laws against rivals both in the form of litigation and attempts to delegate the enforcement effort (and costs) to the government.

Read the full piece here.

Continue reading
Antitrust & Consumer Protection

FTC v. Ovation Opinion

TOTM The opinion in Ovation (i.e. FTC v. Lundbeck) is now available.  The first footnote in Judge Ericksen’s opinion notes that “the FTC and Minnesota began . . .

The opinion in Ovation (i.e. FTC v. Lundbeck) is now available.  The first footnote in Judge Ericksen’s opinion notes that “the FTC and Minnesota began their closing argument by disclaiming the notion that these cases were ‘about unhappiness about the high price of Indocin.’  Nevertheless, the FTC and Minnesota cited in their post-trial response a press release issued by the FTC to announce the action’s commencement.  The press release asserts that the acquisition of NeoProfen resulted in the increase of Indocin IV’s price by almost 1300%; characterizes the prices charged by Lundbeck as ‘artificially high;’ and notes one commissioner’s view that Lundbeck’s ‘profiteering on the backs of critically ill premature babies is not only immoral, it is illegal.”

Read the full piece here

Continue reading
Antitrust & Consumer Protection

The Costs of Product Placement, Maserati Edition

TOTM In my academic research, I’ve studied contractual arrangements between manufacturers and retailers for premium shelf space, including slotting arrangements and category management contracts.  Typically, a . . .

In my academic research, I’ve studied contractual arrangements between manufacturers and retailers for premium shelf space, including slotting arrangements and category management contracts.  Typically, a shelf space arrangement in the retail sector will involve the supplier compensating the retailer for some specified promotional shelving arrangement, e.g. end-caps or eye level space, or a share of the total shelf space dedicated to a particular product category.  These arrangements have much in common with what is commonly referred to as product placement (see also the economics of celebrity endorsements).

Read the full piece here

Continue reading

Allen on Alchian and the UCLA School

TOTM At Econ Journal Watch.   Professor Allen offers a wonderful personal history of the UCLA Economics Department, including the rise and fall of what he describes . . .

At Econ Journal Watch.   Professor Allen offers a wonderful personal history of the UCLA Economics Department, including the rise and fall of what he describes as “the Alchian Department.”    The entire article is worth reading, but I include here an excerpt from Professor Allen’s Nobel (and University Award) nomination on behalf of Armen…

Read the full piece here

Continue reading

The FTC Loses in Ovation Pharmaceuticals

TOTM There are some new developments in the Federal Trade Commission’s consummated merger case brought against Ovation.  Namely, the FTC has lost.  TOTM readers may recall . . .

There are some new developments in the Federal Trade Commission’s consummated merger case brought against Ovation.  Namely, the FTC has lost.  TOTM readers may recall that I spent some time criticizing the Federal Trade Commission’s complaint, back in 2008, in FTC v. Ovation in federal district court in Minnesota.  As I described the stylized facts back then…

Read the full piece here

Continue reading
Antitrust & Consumer Protection